Caribou Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,024 | $3,464 | $2,429 | $3,558 |
Gross Profit | 2,024 | 2,608 | 1,719 | 1,584 |
EBITDA | -38,238 | -42,645 | -45,292 | -36,702 |
EBIT | -43,501 | -46,002 | -38,676 | |
Net Income | -34,684 | -37,697 | -41,234 | -34,505 |
Net Change In Cash | 2,024 | 3,464 | 2,429 | 3,558 |
Free Cash Flow | -33,334 | -35,107 | -38,651 | -23,656 |
Cash | 31,970 | 37,866 | 49,400 | 51,162 |
Basic Shares | 90,455 | 90,340 | 89,302 | 88,432 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $34,477 | $13,851 | $9,598 | $12,361 |
Gross Profit | -77,598 | 10,210 | 8,614 | -22,064 |
EBITDA | -112,534 | -104,777 | -65,995 | -35,207 |
EBIT | -116,059 | -108,418 | -66,979 | -36,107 |
Net Income | -102,070 | -99,421 | -66,923 | -34,308 |
Net Change In Cash | 34,477 | 13,851 | 9,598 | 12,361 |
Cost of Revenue | -182,082 | 224,513 | ||
Free Cash Flow | -104,904 | -98,020 | -35,640 | -34,530 |
Cash | 51,162 | 58,338 | 240,420 | 15,953 |
Basic Shares | 73,807 | 60,801 | 60,263 | 59,970 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.43 |
2024-03-31 | -$0.46 |
2023-12-31 | -$0.39 |
